FDA approves tropinetide for treatment of Rett syndrome

Published Date: 16 Mar 2023

The FDA has approved tropinetide (Daybue; Acadia Pharmaceuticals) to treat Rett syndrome in patients 2 years of age and older.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Lung Cancer Screening Rates in Eligible Adults Remain Low, Uneven

2.

When Should Immunocompromised Individuals Receive a COVID Booster?

3.

The use of biomarkers in the treatment of breast lumps is at a crossroads.

4.

"Unusual" Cancers Following Pandemic; Triumph in TNBC; Clinical Trial Interrupted by Shortage.

5.

Efanesoctocog Alfa Prevented Bleeding in Kids With Severe Hemophilia A


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot